CRH Medical Corp (TSE:CRH) was downgraded by stock analysts at RBC Capital Markets from an “outperform” rating to a “sector perform” rating in a research report issued on Monday. They currently have a C$8.50 price target on the stock, up from their previous price target of C$7.00. RBC Capital Markets’ price objective would indicate a potential upside of 1.67% from the stock’s current price.
Several other research analysts have also commented on the stock. Royal Bank Of Canada boosted their price objective on shares of CRH Medical Corp from C$7.00 to C$8.50 and gave the stock an “outperform” rating in a research note on Monday. CIBC restated an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th. Finally, Bloom Burton restated a “buy” rating on shares of CRH Medical Corp in a research note on Friday, October 28th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. CRH Medical Corp has an average rating of “Buy” and a consensus target price of C$7.57.